[HTML][HTML] Immune evasion in cancer: Mechanistic basis and therapeutic strategies

DS Vinay, EP Ryan, G Pawelec, WH Talib… - Seminars in cancer …, 2015 - Elsevier
Cancer immune evasion is a major stumbling block in designing effective anticancer
therapeutic strategies. Although considerable progress has been made in understanding …

[HTML][HTML] The urgent need to recover MHC class I in cancers for effective immunotherapy

F Garrido, N Aptsiauri, EM Doorduijn, AMG Lora… - Current opinion in …, 2016 - Elsevier
Highlights•Tumor immune escape compromises the efficacy of cancer immunotherapy.•Loss
of MHC class I expression is a frequent event in cancer cells.•Three tumor phenotypes …

Cancer vaccines, adjuvants, and delivery systems

SJ Paston, VA Brentville, P Symonds… - Frontiers in …, 2021 - frontiersin.org
Vaccination was first pioneered in the 18th century by Edward Jenner and eventually led to
the development of the smallpox vaccine and subsequently the eradication of smallpox. The …

Monalizumab: inhibiting the novel immune checkpoint NKG2A

T Van Hall, P André, A Horowitz, DF Ruan… - … for immunotherapy of …, 2019 - Springer
The implementation of immune checkpoint inhibitors to the oncology clinic signified a new
era in cancer treatment. After the first indication of melanoma, an increasing list of additional …

MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells

P Leone, EC Shin, F Perosa, A Vacca… - Journal of the …, 2013 - academic.oup.com
Conditional gene expression has greatly facilitated the examination of the functions of
particular gene products. Using the Cre/lox P switching expression system, we plan to …

The immunology of hormone receptor positive breast cancer

J Goldberg, RG Pastorello, T Vallius, J Davis… - Frontiers in …, 2021 - frontiersin.org
Immune checkpoint blockade (ICB) has revolutionized the treatment of cancer patients. The
main focus of ICB has been on reinvigorating the adaptive immune response, namely …

The role of natural killer T cells in cancer—a phenotypical and functional approach

D Krijgsman, M Hokland, PJK Kuppen - Frontiers in immunology, 2018 - frontiersin.org
Natural killer T (NKT) cells are a subset of CD1d-restricted T cells at the interface between
the innate and adaptive immune system. NKT cells can be subdivided into functional …

Recognition of tumors by the innate immune system and natural killer cells

A Marcus, BG Gowen, TW Thompson, A Iannello… - Advances in …, 2014 - Elsevier
In recent years, roles of the immune system in immune surveillance of cancer have been
explored using a variety of approaches. The roles of the adaptive immune system have been …

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis

A Moretta, C Bottino, M Vitale, D Pende… - Annual review of …, 2001 - annualreviews.org
Natural killer cells can discriminate between normal cells and cells that do not express
adequate amounts of major histocompatibility complex (MHC) class I molecules. The …

The HLA system

JAN Klein, A Sato - New England journal of medicine, 2000 - Mass Medical Soc
A man dies because his body has rejected a heart transplant; a woman is crippled by
rheumatoid arthritis; a child goes into a coma that is brought on by cerebral malaria; another …